D'Orazio & Associates’s Bio-Techne TECH Stock Holding History

D'Orazio & Associates’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-8	Closed	-$1K	–	631
2021 Q3	$1K	Buy	+8	New	+$974	﹤0.01%	751

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

OCBV

Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

D'Orazio & Associates's TECH Position: Q4 2021 in Review

D'Orazio & Associates sold out of Bio-Techne (TECH) in Q4 2021, closing a stake of 8 shares — an estimated $1K sold.

D'Orazio & Associates first reported a position in TECH in Q3 2021 and held it in 1 quarter. The position peaked at $1K in Q3 2021. 575 funds tracked by Wall St. Rank hold TECH as of Q4 2021.

D'Orazio & Associates reported no remaining Bio-Techne position as of Q4 2021 after selling out during the quarter.
D'Orazio & Associates sold 8 Bio-Techne shares in Q4 2021, an estimated $1K.
D'Orazio & Associates first reported a position in Bio-Techne in Q3 2021 and held it in 1 quarter.
D'Orazio & Associates's Bio-Techne position peaked at $1K in Q3 2021.
575 funds tracked by Wall St. Rank held Bio-Techne as of Q4 2021.

Based on D'Orazio & Associates's 13F filing for Q4 2021, filed 7 Feb 2022.